Sentiment Survey
|
|
|
|
|
|
|
|
|
|
|
|
Investment Grade:
|
|
Comments(0)
|
(0)
|
(0)
|
Ranking History
Headlines
- Emergent BioSolutions Hits Investors Business Daily
Dec 01, 2008 02:58 PM
- A New Index Of Emerging Biotech And Pharma Companies
Nov 22, 2008 08:25 PM
- Some Stocks At 52 Week High-AFAM,EBS,CBST
Nov 10, 2008 02:25 PM
- Indices Spike Up In Last Half Hour To Close Substantially Higher
Nov 07, 2008 06:41 PM
- Emergent BioSolutions Earnings - Blowout Quarter
Nov 06, 2008 09:47 PM
- Obama-Care Focused on Preventive Medicine
Nov 05, 2008 07:20 PM
- Indices Come Sharply Off their Lows, But The Bleeding Continues
Oct 25, 2008 02:15 PM
- Friday Stock Fun: Where Are The Profits?
Oct 17, 2008 12:48 PM
- Indices Edge Lower, But Set Up Potentially Bullish Consolidation Patterns
Oct 01, 2008 07:59 PM
- Emergent Biosolutions spent $550K lobbying in 1Q and VIA Pharmaceuticals Set to Join Russell Microcap Index
Jun 30, 2008 09:30 AM
- Blockbuster Digital Media Debut Recalls Enron Venture
Nov 26, 2008 11:57 AM
- Emirates Building Systems Accelerates Regional Expansion With Prestigious Kuwait Project
Oct 16, 2008 03:56 PM
- Leader in Stock Market Game Edges Predecessor By $109
Oct 03, 2008 02:10 AM
- Movers: GE, ImClone Systems, Ford, AIG, Boston Scientific
Oct 02, 2008 10:56 AM
- Alternative-Energy Portfolio Fuels Entrant to 1st
Sep 05, 2008 10:10 AM
- The Daily Record News Briefs: August 14, 2008
Aug 14, 2008 12:55 AM
- Emergent BioSolutions to Webcast Presentation at the
6th Annual Southwestern Showcase Investor Conference on
November 20, 2008
Nov 18, 2008 04:45 PM
- Sixth Annual SOUTHWESTERN SHOWCASE Investor Conference Announces Presenting Company Webcast Schedule
Nov 18, 2008 12:16 PM
- Emergent BioSolutions Files Universal Shelf Registration Statement
Nov 12, 2008 07:21 PM
- Emergent BioSolutions Reports Financial Results for Third Quarter and First Nine Months of 2008
Nov 06, 2008 04:21 PM
- Emergent BioSolutions to Webcast Presentation at the Rodman & Renshaw Annual Global Investment Conference on November 12, 2008
Oct 31, 2008 08:03 AM
- Emergent BioSolutions to Release Third Quarter 2008 Financial Results and Conduct a Conference Call on November 6, 2008
Oct 16, 2008 04:33 PM
- U.S. Government Issues Declaration Covering Emergent BioSolutions' BioThrax(R) and Anthrax Immune Globulin under Prep Act
Oct 09, 2008 07:03 AM
- U.S. Government to Purchase Additional 14.5 Million Doses of BioThrax under New Contract Valued at up to $404 Million
Oct 01, 2008 07:04 AM
- Emergent BioSolutions Signs Contract with BARDA/NIAID, Valued at Up to $29.7 Million, to Fund Development of AV7909 - A Next Generation Anthrax Vaccine
Sep 26, 2008 07:01 AM
- Emergent BioSolutions Notified by HHS That Its Proposal to Provide 25 Million Doses of Its Recombinant Anthrax Vaccine Is Technically Acceptable and Within the Competitive Range
Sep 12, 2008 12:46 PM
- Form 4 Elsey R Don For: Nov 26 (10K)
Dec 01, 2008 04:30 PM
- Form 4/A Emergent BioSolutions For: Nov 12 Filed by: Elsey R Don (10K)
Nov 12, 2008 05:44 PM
- Form 4/A Emergent BioSolutions For: Nov 11 Filed by: Elsey R Don (10K)
Nov 12, 2008 05:30 PM
- Form 4 Emergent BioSolutions For: Nov 10 Filed by: Elsey R Don (10K)
Nov 12, 2008 04:20 PM
- Form 4 Emergent BioSolutions For: Nov 11 Filed by: Keese Kyle (10K)
Nov 12, 2008 04:20 PM
- Form 4 Richard Ronald For: Oct 20 (10K)
Oct 21, 2008 02:22 PM
- Form 4 Elsey R Don For: Oct 20 (10K)
Oct 21, 2008 02:19 PM
- Form 4 Elsey R Don For: Oct 17 (10K)
Oct 20, 2008 04:23 PM
- Form 4 Richard Ronald For: Oct 17 (10K)
Oct 20, 2008 04:23 PM
- Form 4 Emergent BioSolutions For: Oct 14 Filed by: Intervac, L.L.C. (10K)
Oct 16, 2008 05:44 PM
Analyst Ratings
|
|
Share Performance
|
Period
|
EBS
|
Compare to S&P
|
| YTD |
347.04 %
|
632.40 %
|
| 4 Weeks |
25.60 %
|
35.76 %
|
| 12 Weeks |
68.18 %
|
133.12 %
|
|
Financial Ratios
Earnings Performance
|
EPS Growth in Last Quarter: 466.67 %
|
|
EPS Growth in Last Year: 240.00 %
|
|
Sales Growth in Last Quarter: 30.16 %
|
|
Sales Growth in Last Quarter: 29.68 %
|
|
|
